Presentation Outline ICHP Annual Meeting September 13-15

2. Which of the following statements is a reasonable conclusion from the
WARFASA trial?
a. Aspirin 325 mg daily is an effective regimen for further prevention of
unprovoked venous thromboembolism after warfarin treatment is
completed.
b. The risk of bleeding outweighs the benefits of prevention of venous
thromboembolism with aspirin.
c. A low dose of aspirin for further prevention may be considered in
patients with unprovoked venous thromboembolism who have
completed warfarin treatment.
d. The WARFASA trial showed a decrease in venous thromboembolism,
myocardial infarction, and stroke in patients with unprovoked venous
thromboembolism who were treated with aspirin, as compared to
placebo, after warfarin therapy was completed.
3. True/false. Combination therapy of
rifapentine with isoniazid was effective
treatment of latent TB in patients who were
co‐infected co infected with HIV. HIV
a. True
b. False
4. True/false. In combination oral
contraceptives, the type of progestin
correlated to a difference in arterial event risk
when used in combination with 20 µg
estrogen, but not when used in combination
with 30‐40 µg estrogen.
a. True
b. False
8/30/2012
27